LEADER 01326nam  2200409   450 
001 9910707255303321
005 20160614082809.0
035   $a(CKB)5470000002462955
035   $a(OCoLC)951671686
035   $a(OCoLC)995470000002462955
035   $a(EXLCZ)995470000002462955
100   $a20160614d2013      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMemorandum report$ehigh-risk compounded sterile preparations and outsourcing by hospitals that use them
210  1$aWashington, DC :$cDepartment of Health and Human Services, Office of Inspector General,$d2013.
215   $a1 online resource (18 pages) $cillustrations
300   $aTitle from title screen (viewed June 13, 2016).
300   $a"Apr[il] 10 2013."
300   $a"OEI-01-13-00150."
320   $aIncludes bibliographical references.
517   $aMemorandum report 
606   $aMedicare
606   $aDrugs$xDosage forms$zUnited States
606   $aPharmaceutical services$zUnited States
615  0$aMedicare.
615  0$aDrugs$xDosage forms
615  0$aPharmaceutical services
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707255303321
996   $aMemorandum report$93436443
997   $aUNINA